List of insiders holdings for SANGAMO THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BIOGEN INC. Biogen MA Inc. 10% Owner | 2024-08-16 18:40:25 | 3,250,000 0 | 3,250,000 | Form 13G |
| 2 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 2025-08-26 20:05:16 | 2,183,972 0 | 2,183,972 | Form 4 |
| 3 | LANPHIER EDWARD O II Director | 2017-01-13 16:47:38 | 41,663 1,252,119 | 1,293,782 | Form 5 |
| 4 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Former 10% Owner | 2015-09-29 17:08:59 | 1,220,209 0 | 1,220,209 | Form 13G |
| 5 | Kopp LeRoy C 10% Owner | 2007-07-11 13:20:06 | 735,000 277,000 | 1,012,000 | Form 3 |
| 6 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 2025-08-26 19:59:09 | 766,089 0 | 766,089 | Form 4 |
| 7 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | 2025-08-26 20:01:34 | 748,243 0 | 748,243 | Form 4 |
| 8 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 2025-08-26 20:00:14 | 744,487 0 | 744,487 | Form 4 |
| 9 | LOEB GARY EVP, General Counsel & Sec. | 2021-03-25 19:19:47 | 321,257 0 | 321,257 | Form 4 |
| 10 | McClung David Mark EVP, Chief Operating Officer | 2023-11-28 16:19:59 | 212,471 0 | 212,471 | Form 4 |
| 11 | Wolff Henry Ward Exec VP & CFO | 2016-12-14 20:03:38 | 206,829 0 | 206,829 | Form 4 |
| 12 | Davis Gregory D Head of Research & Technology | 2025-08-26 20:03:33 | 201,222 0 | 201,222 | Form 4 |
| 13 | Pooler Amy VP, HEAD OF RESEARCH | 2024-08-27 16:38:12 | 193,923 0 | 193,923 | Form 4 |
| 14 | Schott Robert J. SVP, Head of Development | 2022-03-01 17:20:46 | 186,237 0 | 186,237 | Form 4 |
| 15 | Gregory Philip D SVP of Research & CSO | 2015-06-03 21:06:27 | 177,082 0 | 177,082 | Form 4 |
| 16 | Ramelmeier Rolf Andrew EVP, Technical Operations | 2023-05-30 16:44:36 | 171,467 0 | 171,467 | Form 4 |
| 17 | PARKER H STEWART Director | 2025-06-16 16:05:22 | 162,600 0 | 162,600 | Form 4 |
| 18 | NICHOL GEOFFREY Executive Vice President, R&D | 2015-12-15 17:11:03 | 159,676 0 | 159,676 | Form 4 |
| 19 | Smith Karen L. Director | 2025-06-16 16:05:23 | 152,100 0 | 152,100 | Form 4 |
| 20 | Yi Kathy EVP & Chief Financial Officer | 2019-05-17 17:41:40 | 150,512 0 | 150,512 | Form 4 |
| 21 | Woolfson Adrian EVP Research & Development | 2020-02-27 10:40:43 | 150,000 0 | 150,000 | Form 4 |
| 22 | Meyers James R Director | 2025-06-16 16:05:15 | 149,600 0 | 149,600 | Form 4 |
| 23 | Hillan Kenneth J. Director | 2025-06-16 16:05:14 | 149,600 0 | 149,600 | Form 4 |
| 24 | Carey Robert Director | 2025-06-16 16:05:12 | 149,600 0 | 149,600 | Form 4 |
| 25 | Markels John Director | 2025-06-16 16:05:13 | 146,384 0 | 146,384 | Form 4 |
| 26 | BLUFORD PETER VP, Corporate Development | 2004-10-06 17:38:46 | 135,791 1,200 | 136,991 | Form 4 |
| 27 | Fontenot Jason D. SVP, Chief Scientific Officer | 2023-11-28 16:18:40 | 136,270 0 | 136,270 | Form 4 |
| 28 | Turner Heather D EVP, General Counsel & Sec. | 2019-02-27 20:19:16 | 134,750 0 | 134,750 | Form 4 |
| 29 | Horn Margaret A Director | 2025-06-16 16:05:10 | 132,650 0 | 132,650 | Form 4 |
| 30 | Beers Courtney Director | 2025-06-16 16:05:07 | 132,650 0 | 132,650 | Form 4 |
| 31 | ANDO DALE G VP, Therapeutic Dev. & CMO | 2015-12-15 17:12:42 | 107,328 0 | 107,328 | Form 4 |
| 32 | Lee Sung EVP, Chief Financial Officer | 2020-11-30 19:46:14 | 88,708 0 | 88,708 | Form 4 |
| 33 | Zakrzewski Joseph S Director | 2022-03-01 17:15:06 | 85,700 0 | 85,700 | Form 4 |
| 34 | Mento Steven J Director | 2018-06-12 20:26:37 | 29,332 32,214 | 61,546 | Form 4 |
| 35 | Ramasastry Saira Director | 2022-03-01 17:13:17 | 60,700 0 | 60,700 | Form 4 |
| 36 | DILLY STEPHEN GEORGE Director | 2020-06-03 16:27:37 | 35,000 0 | 35,000 | Form 4/A |
| 37 | Ichikawa David G Senior VP, Bus. Dev. | 2011-12-12 20:53:03 | 25,000 0 | 25,000 | Form 4 |
| 38 | ZANTE GREG VP, Finance & Administration | 2008-03-12 19:41:56 | 24,552 0 | 24,552 | Form 4 |
| 39 | CASE CASEY C VP, Research & Operations | 2004-12-22 14:12:49 | 20,000 0 | 20,000 | Form 4 |
| 40 | Herberts Curt A. III Sr.VP & Chief Business Officer | 2018-04-17 16:16:03 | 18,375 0 | 18,375 | Form 4 |
| 41 | Conner Edward R. Sr. VP & Chief Medical Officer | 2019-01-28 17:46:59 | 11,291 0 | 11,291 | Form 4 |
| 42 | Liu Margaret Director | 2008-06-06 17:45:38 | 10,000 0 | 10,000 | Form 4 |
| 43 | WOOD MICHAEL C Director | 2008-06-06 17:46:46 | 10,000 0 | 10,000 | Form 4 |
| 44 | GERBER WILLIAM G Director | 2010-06-03 17:01:32 | 10,000 0 | 10,000 | Form 4 |
| 45 | JACOBY JON E M Director | 2005-06-07 12:02:33 | 10,000 0 | 10,000 | Form 4 |
| 46 | RUTTER WILLIAM J Director | 2004-06-14 14:06:14 | 10,000 0 | 10,000 | Form 4 |
| 47 | WIGGANS THOMAS G Director | 2011-06-03 17:33:11 | 10,000 0 | 10,000 | Form 4 |
| 48 | LARSON JOHN WILLIAM Director | 2015-06-24 17:05:42 | 10,000 0 | 10,000 | Form 4 |
| 49 | Cleveland Paul B Director | 2016-06-15 20:24:16 | 10,000 0 | 10,000 | Form 4 |
| 50 | JEFFS ROGER Director | 2018-09-07 19:18:12 | 9,908 0 | 9,908 | Form 4 |
| 51 | RINGO WILLIAM R Director | 2017-09-22 16:04:42 | 800 0 | 800 | Form 4 |
| 52 | Boissel Stephane EVP, Corp. Strategy | 2020-07-31 20:16:25 | 3 0 | 3 | Form 4 |